| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Samira Shaikhly | Chief People Officer | 2026-03-02 | 5,101 | $2.76 | $14.08kBuy |
| Samira Shaikhly | Chief People Officer | 2026-03-02 | 11,638 | $2.76 | $32.12kBuy |
| Samira Shaikhly | Chief People Officer | 2026-03-02 | 53,714 | $1.55 | $83.26kBuy |
| Samira Shaikhly | Chief People Officer | 2026-03-02 | 66,363 | $28.14 | $1.87MSell |
| Samira Shaikhly | Chief People Officer | 2026-03-02 | 4,090 | $27.51 | $112.50kSell |
| Elizabeth Bhatt | President and COO | 2026-02-18 | 4,000 | $6.81 | $27.24kBuy |
| Elizabeth Bhatt | President and COO | 2026-02-18 | 2,200 | $28.46 | $62.61kSell |
| Elizabeth Bhatt | President and COO | 2026-02-18 | 1,800 | $29.58 | $53.25kSell |
| Daniel D. Long | SVP Drug Discovery | 2025-11-10 | 3,501 | $18.06 | $63.22kSell |
| Uwe Klein | SVP Biological Sciences | 2025-08-18 | 10,452 | $2.76 | $28.85kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Third Rock Ventures VI LP | 23.22% | 10,427,250 | $262.14M | Insider |
| Third Rock Ventures V LP | 20.86% | 9,368,047 | $235.51M | Insider |
| Ra Capital Management LP | 15.58% | 6,995,858 | $175.88M | Institution |
| Trv GP V LLC | 13.84% | 6,215,591 | $156.26M | Institution |
| Driehaus Capital Management LLC | 10.71% | 4,809,470 | $120.91M | Institution |
| Trv GP VI LLC | 9.38% | 4,211,659 | $105.88M | Institution |
| Samsara Biocapital LLC | 7.01% | 3,149,128 | $79.17M | Institution |
| Goldman Sachs Group Inc | 6.05% | 2,715,129 | $68.26M | Institution |
| Siren LLC | 4.45% | 2,000,000 | $50.28M | Institution |
| Blackrock Inc | 4.01% | 1,801,328 | $45.29M | Institution |